Pulmonary delivery of insulin by liposomal carriers
Authors:
- Yi-You HuangYHYi-You Huang
- Ching-Hua WangCWChing-Hua Wang
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 113 (1) , 9-14
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy of Nebulized Liposomal Amphotericin B in Treatment of Experimental Pulmonary AspergillosisAntimicrobial Agents and Chemotherapy, 2005
- The Lungs as a Portal of Entry for Systemic Drug DeliveryProceedings of the American Thoracic Society, 2004
- Interleukin-2 liposomes for primary immune deficiency using the aerosol routeInternational Immunopharmacology, 2002
- Large Porous Particles for Pulmonary Drug DeliveryScience, 1997
- Mechanisms of macromolecule absorption by the lungsAdvanced Drug Delivery Reviews, 1996
- A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal deliveryJournal of Controlled Release, 1995
- Absorption Enhancement of Intrapulmonary Administered Insulin by Various Absorption Enhancers and Protease Inhibitors in RatsJournal of Pharmacy and Pharmacology, 1994
- Aerosol amphotericin B for prevention of invasive pulmonary aspergillosisAntimicrobial Agents and Chemotherapy, 1993
- Pulmonary Delivery of Free and Liposomal InsulinPharmaceutical Research, 1993
- Intratracheal delivery of insulin Absorption from solution and aerosol by rat lungInternational Journal of Pharmaceutics, 1992